Publication: Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
Loading...
Identifiers
Date
2020-09-02
Authors
Soria-Juan, Bárbara
Escacena, Natalia
Capilla-González, Vivian
Aguilera, Yolanda
Llanos, Lucía
Tejedo, Juan R
Bedoya, Francisco J
Juan, Verónica
De la Cuesta, Antonio
Ruiz-Salmerón, Rafael
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
[This corrects the article DOI: 10.3389/fimmu.2019.01151.].
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
cell-based therapy, cellular medicaments, clinical trials, cost-effective, critical limb ischemia, diabetes